GLP1R and type 2 diabetes mellitus: Interestingly, monomeric GLP-1R agonists, like semaglutide and liraglutide, as well as dual GLP-1R agonists like tirzepatide, have been FDA-approved for the treatment of T2DM and metabolic disorders, including chronic weight management in adults with obesity [32,33].